Compare JBI & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBI | THQ |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.7M | 779.0M |
| IPO Year | 2021 | N/A |
| Metric | JBI | THQ |
|---|---|---|
| Price | $5.05 | $19.53 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.17 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 182.0K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.36 | N/A |
| Revenue Next Year | $3.16 | N/A |
| P/E Ratio | $62.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.26 | $16.28 |
| 52 Week High | $10.80 | $20.39 |
| Indicator | JBI | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 66.87 |
| Support Level | $4.91 | $18.90 |
| Resistance Level | $5.58 | $20.14 |
| Average True Range (ATR) | 0.22 | 0.20 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 36.71 | 92.38 |
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. It provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.